We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
-$36.6M
Cap. Flow
-$73.8M
Cap. Flow %
-0.42%
Top 10 Hldgs %
30.57%
Holding
716
New
41
Increased
319
Reduced
225
Closed
41

Top Buys

Rank Stock Value
1
WM icon
Waste Management
WM
+$59.7M
2
MSFT icon
Microsoft
MSFT
+$55.1M
3
MA icon
Mastercard
MA
+$53.2M
4
LRCX icon
Lam Research
LRCX
+$52M
5
WMT icon
Walmart Inc
WMT
+$52M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$71.1M
2
UNH icon
UnitedHealth
UNH
+$65.8M
3
AMGN icon
Amgen
AMGN
+$58M
4
IQV icon
IQVIA
IQV
+$50.8M
5
CSCO icon
Cisco
CSCO
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 33.5%
2 Healthcare 24.06%
3 Financials 11.65%
4 Consumer Discretionary 8.41%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BR icon
376
Broadridge
BR
$18.4B
$4.16M 0.02%
18,378
+4,229
+30% +$947K
ZWS icon
377
Zurn Elkay Water Solutions
ZWS
$8.6B
$4.12M 0.02%
110,548
+12,703
+13% +$484K
DLR icon
378
Digital Realty Trust
DLR
$69.6B
$4.12M 0.02%
23,234
+1,295
+6% +$230K
CCI icon
379
Crown Castle
CCI
$34.6B
$4.08M 0.02%
44,981
+8,581
+24% +$897K
IMCR icon
380
Immunocore
IMCR
$1.7B
$3.98M 0.02%
134,785
-5,221
-4% -$165K
NEM icon
381
Newmont
NEM
$96.2B
$3.95M 0.02%
106,216
+22,007
+26% +$1M
SUPN icon
382
Supernus Pharmaceuticals
SUPN
$2.7B
$3.95M 0.02%
109,327
-32,562
-23% -$1.15M
ABNB icon
383
Airbnb
ABNB
$90.8B
$3.94M 0.02%
29,969
+2,703
+10% +$364K
DXCM icon
384
DexCom
DXCM
$29B
$3.94M 0.02%
50,610
-179,841
-78% -$13.3M
APGE icon
385
Apogee Therapeutics
APGE
$10.1B
$3.88M 0.02%
85,661
-4,339
-5% -$221K
MPC icon
386
Marathon Petroleum
MPC
$90.1B
$3.86M 0.02%
27,677
+1,335
+5% +$204K
BKR icon
387
Baker Hughes
BKR
$58.3B
$3.84M 0.02%
93,496
+3,644
+4% +$147K
MLYS icon
388
Mineralys Therapeutics
MLYS
$2.32B
$3.76M 0.02%
+305,272
New +$3.99M
ACGL icon
389
Arch Capital
ACGL
$36.5B
$3.75M 0.02%
40,597
+8,606
+27% +$869K
IT icon
390
Gartner
IT
$11.1B
$3.74M 0.02%
7,718
+1,210
+19% +$624K
ENSG icon
391
The Ensign Group
ENSG
$10.6B
$3.7M 0.02%
+27,865
New +$4.05M
KURA icon
392
Kura Oncology
KURA
$793M
$3.68M 0.02%
422,652
-483,830
-53% -$6.96M
HWM icon
393
Howmet Aerospace
HWM
$109B
$3.62M 0.02%
33,143
+2,999
+10% +$328K
DASH icon
394
DoorDash
DASH
$84.3B
$3.61M 0.02%
21,535
+2,285
+12% +$375K
FAST icon
395
Fastenal
FAST
$54.8B
$3.58M 0.02%
99,472
-2,928
-3% -$114K
HIW icon
396
Highwoods Properties
HIW
$3.79B
$3.56M 0.02%
116,303
+65,377
+128% +$2.13M
BHVN icon
397
Biohaven
BHVN
$2.02B
$3.55M 0.02%
95,179
-4,821
-5% -$225K
AYI icon
398
Acuity Brands
AYI
$9.99B
$3.55M 0.02%
12,161
-4,285
-26% -$1.34M
RRX icon
399
Regal Rexnord
RRX
$12.5B
$3.54M 0.02%
+22,805
New +$3.85M
HPQ icon
400
HP
HPQ
$26B
$3.53M 0.02%
108,038
+14,334
+15% +$515K

Similar funds

Candriam SCA's Q4 2024 Portfolio in Review

As of Q4 2024, Candriam SCA held 716 positions worth $17.4B, down 0.21% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q4 2024 filing shows 41 new, 319 increased, 225 reduced and 41 closed positions. Its largest new stake was Lam Research: 685,631 shares worth $49.5M. The largest sale was Alphabet (Google) Class A, an estimated $71.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2024 buy was Lam Research: 685,631 shares worth $49.5M.
  • Candriam SCA added most to Waste Management in Q4 2024, an estimated $59.7M increase.
  • Candriam SCA's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $71.1M.
  • Candriam SCA fully exited Kanzhun in Q4 2024, selling an estimated $22.5M.
  • Candriam SCA's ten largest holdings make up 31% of its $17.4B portfolio in Q4 2024.
  • Candriam SCA opened 41 new positions and closed 41 in Q4 2024.
  • Candriam SCA's portfolio value fell 0.21% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.